Acute Porphyria Drug Database

C10AB02 - Bezafibrate
Propably not porphyrinogenic
PNP

Rationale
Substrate of CYP 3A4. Two references stating non-porphyrinogenicity. Occasional clinical experience of non-porphyrinogenicity
Chemical description
Cholesterol lowering clofibrate derivative, dose 600 mg/d. 95 % absorbed from the gut. Metabolized by CYP 3A4 . No data pointing to CYP-induction. Thunell, patient report (n=1): tolerated. Andersson, patient report (n=3): tolerated. South African list: use with care French list: authorized
IPNet drug reports
Uneventful use reported in 9 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes C10A / C10AB or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙